Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,238.00    -18.00 (-1.43%)
Bid:
1,238.00
Ask:
1,244.00
Spread: 6.00 (0.485%)
Market Cap: £567.33m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

25 Jul 2016 07:00

RNS Number : 0496F
Cohort PLC
22 July 2016
 

25 July 2016

 

Cohort plc

("Cohort" or "the Group")

 

Contract Win

MCL awarded Airborne Tactical Communications Support Contract

Cohort, the independent technology group, today announces that its subsidiary Marlborough Communications Ltd (MCL), has been awarded the UK MOD Airborne Tactical Communications Support Contract.

The contract, valued at up to £7.7m, is to provide support to certain specialist equipment and includes options covering additional development activities. The duration of the contract will be between two and six years, with a minimum value of around £0.9m, depending on the options chosen by the customer. MCL will be supported by its partner Serbus Ltd in the delivery of the contract.

Andrew Thomis, Chief Executive of Cohort plc said:

"This is another excellent win for MCL demonstrating its extremely strong capability in this specialist area. After many years successfully delivering land based tactical communications, we are pleased to have built on this experience enabling this, our first win in the tactical airborne environment.

"This adds further visibility to our order book, which underpins a significant proportion of revenues for Cohort's current financial year."

Ends

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

Investec Bank plc

020 7597 5970

Keith Anderson / Daniel Adams

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Jamie Ricketts / Ollie Hoare

 

 

NOTES TO EDITORS

Cohort plc (www.cohortplc.com) is the parent company for five innovative, agile and responsive businesses working primarily for defence, wider government and industry clients. 

· EID (www.eid.pt) - a Portugal based supplier of advanced communications products and systems for the global defence market. EID has been part of the Group since June 2016.

 

· MASS (www.mass.co.uk) - a specialist defence and technology business, focused mainly on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006.

· MCL (www.marlboroughcomms.com) - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014.

 

· SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with armed forces experience and domain knowledge. Owned by Cohort since flotation in March 2006. 

 

· SEA (www.sea.co.uk) - an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007. 

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 800 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey, Scotland and Portugal.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTAKBDBABKDDOB
Date   Source Headline
6th Aug 20217:00 amRNSMCL wins contracts with MoD
5th Aug 20211:42 pmRNSDirector/PDMR Shareholding
5th Aug 20219:41 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSAppointment of Non-Executive Director
27th Jul 20217:00 amRNSPreliminary Results
14th Jul 202111:58 amRNSNotice of Results
7th Jul 20217:00 amRNSELAC SONAR wins EUR49m contract for Italian Navy
10th Jun 20213:35 pmRNSHolding(s) in Company
1st Jun 20214:41 pmRNSSecond Price Monitoring Extn
1st Jun 20214:35 pmRNSPrice Monitoring Extension
26th May 20217:00 amRNSTrading Update
25th May 20214:40 pmRNSSecond Price Monitoring Extn
25th May 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20212:01 pmRNSTotal Voting Rights
6th Apr 20212:10 pmRNSDirector/PDMR Shareholding
1st Apr 202110:28 amRNSTotal Voting Rights
1st Apr 202110:27 amRNSBlock listing Interim Review
31st Mar 20214:45 pmRNSHolding(s) in Company
29th Mar 20212:40 pmRNSSEA wins £25m contract with UK MoD
11th Mar 20217:00 amRNSContract Wins
3rd Mar 20212:05 pmRNSResponse to Press Speculation
26th Feb 20212:30 pmRNSTotal Voting Rights
24th Feb 20214:42 pmRNSBlock listing Interim Review
11th Feb 20215:41 pmRNSDirector/PDMR Shareholding
9th Feb 20219:30 amRNSEBT Purchase of Shares
8th Feb 20215:31 pmRNSDirector/PDMR Shareholding
29th Jan 202110:31 amRNSTotal Voting Rights
12th Jan 20216:10 pmRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSInterim Report
31st Dec 20209:22 amRNSTotal Voting Rights
14th Dec 20201:51 pmRNSEBT Purchase of Shares
11th Dec 20202:12 pmRNSDirector/PDMR Shareholding
10th Dec 20205:35 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSHalf Year Results
3rd Dec 20207:00 amRNSCompletion of Acquisition
30th Nov 202011:21 amRNSTotal Voting Rights
19th Nov 20207:00 amRNSNotice of Interim Results Date
4th Nov 20201:24 pmRNSTotal Voting Rights
30th Oct 20204:59 pmRNSTotal Voting Rights
26th Oct 20206:13 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSContract Wins
14th Oct 20202:53 pmRNSDirector/PDMR Shareholding
5th Oct 20205:58 pmRNSEBT purchase and exercise of Share Options
28th Sep 20202:36 pmRNSBlock Listing Application
25th Sep 20205:10 pmRNSDirector/PDMR Shareholding
21st Sep 20202:05 pmRNSEBT Purchase and Director Shareholdings
15th Sep 20203:39 pmRNSResult of AGM
15th Sep 20201:13 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSAGM Statement & First Quarter Update
10th Sep 20203:28 pmRNSAGM Shareholder Q&A – Joining Instructions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.